Disturbance of Growth
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Low-protein Infant Formula With Partial or Extensive Proteinhydrolysate 4 Year Follow-up (NCT01143233) | HiPP GmbH & Co. Vertrieb KG | 2010-04-01 |
Track Disturbance of Growth automatically
Every clearance here is in the API, with alerts when new ones post.